Literature DB >> 23871851

In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs.

Mohammad Aref1, Maxime A Gallant, Jason M Organ, Joseph M Wallace, Christopher L Newman, David B Burr, Drew M Brown, Matthew R Allen.   

Abstract

Raloxifene treatment has been shown previously to positively affect bone mechanical properties following 1 year of treatment in skeletally mature dogs. Reference point indentation (RPI) can be used for in vivo assessment of mechanical properties and has been shown to produce values that are highly correlated with properties derived from traditional mechanical testing. The goal of this study was to use RPI to determine if raloxifene-induced alterations in mechanical properties occurred after 6 months of treatment. Twelve skeletally mature female beagle dogs were treated for 6 months with oral doses of saline vehicle (VEH, 1 ml/kg/day) or a clinically relevant dose of raloxifene (RAL, 0.5 mg/kg/day). At 6 months, all animals underwent in vivo RPI (10N force, 10 cycles) of the anterior tibial midshaft. RPI data were analyzed using a custom MATLAB program, designed to provide cycle-by-cycle data from the RPI test and validated against the manufacturer-provided software. Indentation distance increase (IDI), a parameter that is inversely related to bone toughness, was significantly lower in RAL-treated animals compared to VEH (-16.5%), suggesting increased bone toughness. Energy absorption within the first cycle was significantly lower with RAL compared to VEH (-21%). These data build on previous work that has documented positive effects of raloxifene on material properties by showing that these changes exist after 6 months.
© 2013.

Entities:  

Keywords:  Bone mechanics; Bone remodeling; Indentation; Osteoporosis treatments

Mesh:

Substances:

Year:  2013        PMID: 23871851      PMCID: PMC3873633          DOI: 10.1016/j.bone.2013.07.009

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density.

Authors:  B Lawrence Riggs; L Joseph Melton
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

2.  Raloxifene enhances vertebral mechanical properties independent of bone density.

Authors:  Matthew R Allen; Ken Iwata; Masahiko Sato; David B Burr
Journal:  Bone       Date:  2006-06-30       Impact factor: 4.398

3.  Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing.

Authors:  Maxime A Gallant; Drew M Brown; Jason M Organ; Matthew R Allen; David B Burr
Journal:  Bone       Date:  2012-12-27       Impact factor: 4.398

4.  Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.

Authors:  Somnath Sarkar; Bruce H Mitlak; Mayme Wong; John L Stock; Dennis M Black; Kristine D Harper
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

5.  Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone.

Authors:  Matthew R Allen; Harry A Hogan; Wesley A Hobbs; Andrew S Koivuniemi; Mark C Koivuniemi; David B Burr
Journal:  Endocrinology       Date:  2007-05-03       Impact factor: 4.736

6.  Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls.

Authors:  Roberto C Güerri-Fernández; Xavier Nogués; José M Quesada Gómez; Elisa Torres Del Pliego; Lluís Puig; Natalia García-Giralt; Guy Yoskovitz; Leonardo Mellibovsky; Paul K Hansma; Adolfo Díez-Pérez
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

7.  Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans.

Authors:  Tony M Keaveny; Paul F Hoffmann; Mandeep Singh; Lisa Palermo; John P Bilezikian; Susan L Greenspan; Dennis M Black
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

Review 8.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

9.  Microindentation for in vivo measurement of bone tissue mechanical properties in humans.

Authors:  Adolfo Diez-Perez; Roberto Güerri; Xavier Nogues; Enric Cáceres; Maria Jesus Peña; Leonardo Mellibovsky; Connor Randall; Daniel Bridges; James C Weaver; Alexander Proctor; Davis Brimer; Kurt J Koester; Robert O Ritchie; Paul K Hansma
Journal:  J Bone Miner Res       Date:  2010-08       Impact factor: 6.741

10.  Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.

Authors:  Matthew R Allen; Daniel J Kubek; David B Burr
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

View more
  22 in total

1.  In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Authors:  Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

2.  Variability of in vivo reference point indentation in skeletally mature inbred rats.

Authors:  Matthew R Allen; Christopher L Newman; Eric Smith; Drew M Brown; Jason M Organ
Journal:  J Biomech       Date:  2014-05-08       Impact factor: 2.712

3.  In vivo reference point indentation measurement variability in skeletally mature inbred mice.

Authors:  Andrew Srisuwananukorn; Matthew R Allen; Drew M Brown; Joseph M Wallace; Jason M Organ
Journal:  Bonekey Rep       Date:  2015-06-17

4.  Identifying Novel Clinical Surrogates to Assess Human Bone Fracture Toughness.

Authors:  Mathilde Granke; Alexander J Makowski; Sasidhar Uppuganti; Mark D Does; Jeffry S Nyman
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

5.  Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.

Authors:  Cory N Meixner; Mohammad W Aref; Aryaman Gupta; Erin M B McNerny; Drew Brown; Joseph M Wallace; Matthew R Allen
Journal:  Calcif Tissue Int       Date:  2017-02-28       Impact factor: 4.333

6.  Insights into reference point indentation involving human cortical bone: sensitivity to tissue anisotropy and mechanical behavior.

Authors:  Mathilde Granke; Aurélie Coulmier; Sasidhar Uppuganti; Jennifer A Gaddy; Mark D Does; Jeffry S Nyman
Journal:  J Mech Behav Biomed Mater       Date:  2014-05-27

7.  Strain differences in the attenuation of bone accrual in a young growing mouse model of insulin resistance.

Authors:  Elizabeth Rendina-Ruedy; Jennifer L Graef; McKale R Davis; Kelsey D Hembree; Jeffrey M Gimble; Stephen L Clarke; Edralin A Lucas; Brenda J Smith
Journal:  J Bone Miner Metab       Date:  2015-06-10       Impact factor: 2.626

8.  Tracing the pathway of compositional changes in bone mineral with age: preliminary study of bioapatite aging in hypermineralized dolphin's bulla.

Authors:  Zhen Li; Jill D Pasteris
Journal:  Biochim Biophys Acta       Date:  2014-03-17

9.  A novel approach to evaluate the effect of medicaments used in endodontic regeneration on root canal surface indentation.

Authors:  Ghaeth H Yassen; Tien-Min G Chu; Maxime A Gallant; Matthew R Allen; Mychel M Vail; Peter E Murray; Jeffrey A Platt
Journal:  Clin Oral Investig       Date:  2013-10-08       Impact factor: 3.573

Review 10.  Novel assessment tools for osteoporosis diagnosis and treatment.

Authors:  Bo Gong; Gurjit S Mandair; Felix W Wehrli; Michael D Morris
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.